|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| bis(2-(Dimethylamino)ethyl)ether | CAS 3033-62-3 | ||
| C8H20N2O | RTECS KR9460000 | ||
|
Synonyms & Trade Names NIAX® A99; NIAX® Catalyst A1; 2,2'-Oxybis(N,N-dimethyl ethylamine) [Note: A component (5%) of NIAX® Catalyst ESN, along with dimethylaminopropionitrile (95%).] |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: See Appendix C (NIAX® Catalyst ESN) | ||
| OSHA PEL: See Appendix C (NIAX® Catalyst ESN) | |||
| IDLH N.D. | Conversion | ||
|
Physical Description Liquid. |
|||
|
MW: 160.3 |
BP: 372°F |
FRZ: ? |
Sol: ? |
|
VP: ? |
IP: ? |
|
Sp.Gr: ? |
|
Fl.P: ? |
UEL: ? |
LEL: ? |
|
|
Incompatibilities & Reactivities None reported |
|||
|
Measurement Methods None available |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Possible urinary disturbance, neurological disorders; in animals: irritation eyes, skin | |
|
Target Organs
Eyes, skin, urinary tract, peripheral nervous system |
|
| See also: INTRODUCTION |